Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients

NCT01270997 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Etanercept
BIOLOGICAL: Etanercept

Sponsor

Hanwha Chemical